Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Celldex Therapeutics, Inc.

TRADE

NASDAQ: CLDXHealthcare / Biotechnology / USA
0.45+0.03+7.14%Vol 4 990 6911Y Perf -85.20%
Oct 16th, 2018 16:00
BID0.44 ASK0.46
Open0.42 Previous Close0.42
Pre-Market0.40 After-Trading0.47
 -0.02 -4.76%  0.02 4.44%
Target Price
1.33 
Analyst Rating
Moderate Buy 2.33
Potencial %
195.56 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★★     57.61
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)73 
Earnings Rating
Sell
Price Range Ratio 52wk %
1.85 
Earnings Date
6th Nov 2018

Today's Price Range

0.400.47

 

52wk Range

0.403.10

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
7.14%
3 Months
-13.46%
6 Months
-43.04%
1 Year
-85.20%
3 Years
-96.78%
5 Years
-98.33%

Quotes

Name / TickerPriceChg.Chg.%
CLDX0.450.03007.14
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.90
Current Ratio 6.00
Long Term Debt to Total Capital -
Total Debt to Equity 0.03
Interest Coverage -
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-507.80
EBITDA Margin-474.50
Pre-tax Profit Margin-2 082.50
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.53
PS Ratios 6.63
Price to Cash Flow 8.30
Price to Free Cash Flow -1.00
Cash Flow Per Share -0.64
Price to Tangible Book0.86
Book Value per Share0.79
Enterprise Value (in ths.)-45 783
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-44.62
ROE last 12 Months -90.33
Return on Assets (5Y Avg) -41.59
ROA last 12 Months -61.90
Return on Capital (5Y Avg) -43.21
ROC last 12 Months -91.65
Return on invested Capital Q -12.52
Return on invested Capital Y-36.13
Assets Turnover0.00
Receivables Turnover3.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 290
Revenue per Share 0.06
Revenue Growth 3 Years 29.11
Revenue Growth 5 Years 19.91
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.14-0.1121.43
Q01 2018-0.17-0.19-11.76
Q04 2017-0.23-0.1726.09
Q03 2017-0.24-0.1441.67
Q02 2017-0.25-0.238.00
Q01 2017-0.28-0.280.00
Q04 2016-0.34-0.3011.76
Q03 2016-0.32-0.299.38
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.12-9.09Negative
12/2018 QR-0.0918.18Positive
12/2018 FY-0.4413.73Positive
12/2019 FY-0.538.62Positive
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.12
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume4 990 691
Shares Outstanding (in ths.)162 440
Trades Count5 828
Dollar Volume2 067 114
Avg. Volume2 237 597
Avg. Weekly Volume2 140 195
Avg. Monthly Volume1 507 409
Avg. Quarterly Volume1 433 214

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

71%29%

Bearish Bullish

78%22%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.33
Moderate Buy
2.33

There are no comments yet.

News

x